石药集团(01093)：受托人根据股份奖励计划购买合共50.4万股股份

Core Viewpoint - The company, Stone Pharmaceutical Group, announced the purchase of a total of 504,000 shares under its share award plan, which will be held in trust for the benefit of selected participants [1] Group 1 - The shares will be purchased on October 15, 2025, by a trustee according to the terms and conditions of the share award plan [1] - The purchased shares will be held in trust for the benefit of selected participants [1]